Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. / Asmar, Meena; Holst, Jens Juul.

In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 17, No. 1, 01.02.2010, p. 57-62.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Asmar, M & Holst, JJ 2010, 'Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances', Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 1, pp. 57-62.

APA

Asmar, M., & Holst, J. J. (2010). Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Current Opinion in Endocrinology, Diabetes and Obesity, 17(1), 57-62.

Vancouver

Asmar M, Holst JJ. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Current Opinion in Endocrinology, Diabetes and Obesity. 2010 Feb 1;17(1):57-62.

Author

Asmar, Meena ; Holst, Jens Juul. / Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. In: Current Opinion in Endocrinology, Diabetes and Obesity. 2010 ; Vol. 17, No. 1. pp. 57-62.

Bibtex

@article{8ffe45f67b5e482f9108287927da1a56,
title = "Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances",
abstract = "This article highlights recent advances in our understanding of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) physiology and their various sites of action beyond the incretin effect.",
keywords = "Adipocytes, Animals, Bone and Bones, Cardiovascular Physiological Processes, Central Nervous System, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Humans, Insulin-Secreting Cells, Lipid Metabolism, Peripheral Nervous System, Receptors, Gastrointestinal Hormone",
author = "Meena Asmar and Holst, {Jens Juul}",
year = "2010",
month = feb,
day = "1",
language = "English",
volume = "17",
pages = "57--62",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances

AU - Asmar, Meena

AU - Holst, Jens Juul

PY - 2010/2/1

Y1 - 2010/2/1

N2 - This article highlights recent advances in our understanding of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) physiology and their various sites of action beyond the incretin effect.

AB - This article highlights recent advances in our understanding of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) physiology and their various sites of action beyond the incretin effect.

KW - Adipocytes

KW - Animals

KW - Bone and Bones

KW - Cardiovascular Physiological Processes

KW - Central Nervous System

KW - Gastric Inhibitory Polypeptide

KW - Glucagon-Like Peptide 1

KW - Humans

KW - Insulin-Secreting Cells

KW - Lipid Metabolism

KW - Peripheral Nervous System

KW - Receptors, Gastrointestinal Hormone

M3 - Journal article

C2 - 19881341

VL - 17

SP - 57

EP - 62

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 1

ER -

ID: 33940651